Speakers will present categorization of the 5 platforms -- including relatively mainstream strategies -- Neoantigen Platform, Tumor-associated Antigens Platform, Cellular Platform, and Oncolytic Viruses Platform -- and the latest breakthrough and a potentially disruptive research strategy --  Antigenic Essence Platform. 

The webinar will host research and business presentations from the Deep Pharma Intelligence team and guest speaker presentations by invited industry experts.